Skip to main content
SpringerLink
Log in

General Pharmacology of Glucosidase Inhibitors

  • Chapter
Oral Antidiabetics

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 119))

  • 653 Accesses

Abstract

Various pharmacological studies have been carried out on α-glucosidase inhibitors using abnormally high doses in animal experiments or excessively high concentrations in in vitro assays in order to detect adverse effects. This chapter briefly reviews the results of these studies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Atai H, Tsuda T, Suzuki S (1989) Antigenicity study of BAY g 5421 in guinea pigs and mice. Precl Rep Cont Inst Exp Anim 15:19–28

    CAS  Google Scholar 

  • Bourbon JR, Doucet E, Rieutort M (1987) Role of α-glucosidase in fetal lung maturation. Biochim Biophys Acta 917:203–210

    Article  PubMed  CAS  Google Scholar 

  • Gardner PJ (1984) BAY g 5421: General/safety respiratory pharmacology: evaluation in the guinea pig isolated trachea. Pharma Report No. 2893, Bayer AG

    Google Scholar 

  • Garthoff B (1980a) BAY g 5421 — test of the diuretic action in rats. Pharma Report No. 9112, Bayer AG

    Google Scholar 

  • Garthoff B (1980b) BAY m 1099 — test of the diuretic action in rats. Pharma Report No. 9360, Bayer AG

    Google Scholar 

  • Garthoff B (1981a) BAY o 1248 — test of the diuretic action in rats. Pharma Report 10085, Bayer AG

    Google Scholar 

  • Garthoff B (1981b) BAY m 1099 — effect on the haemodynamics and on the cardiac contractility of anaesthetised dogs after oral administration. Pharma Report No. 9849, Bayer AG

    Google Scholar 

  • Garthoff B (1982) BAY o 1248 — effect on the haemodynamics and on the cardiac contractility of anaethetised dogs after oral administration. Pharma Report No. 10943, Bayer AG

    Google Scholar 

  • Hammond MD, Coomber JS (1984) Bay g 5421, general respiratory pharmacology: antiallergic and Pseudoallergic activity. Pharma Report, Bayer AG, No. R2812

    Google Scholar 

  • Hoffmeister F (1982) Influence of acarbose with and without glisoxepide on the spontaneous EEG and the electroencephalogram during an infusion of penetrazole in rabbits. Pharma Report No. 10881, Bayer AG

    Google Scholar 

  • Jacobi H, Neuser V (1994) BAY o 1248: effect on the central nervous system after oral and intraduodenal administration (mouse, rat and cat). Pharma Report No. TR-10713, Bayer AG

    Google Scholar 

  • Kito G (1991) General pharmacological studies on AO-128. Jpn Pharm Ther 19:231–245

    Google Scholar 

  • Krause HP, Hoffmeister F (1980a) BAY g 5421 — test for central nervous actions. Pharma Report No. 9423, Bayer AG

    Google Scholar 

  • Krause HP, Hoffmeister F (1980b) BAY m 1099 — test for central nervous actions. Pharma Report No. 9437, Bayer AG

    Google Scholar 

  • Samueli F, Bonabello A, Grassi A (1984) Bay g 5421 — effect on isolated guinea pig ileum spasm, on stimulated gastric secretion and on experimental gastric ulcers in rats. Pharma Report No. 2859, Bayer AG

    Google Scholar 

  • Samueli F, Bonabello A, Grassi A (1985) BAY g 5421 -effect on intestinal charcoal transit in mouse, on gastric tolerability and on basal secretion in rat. Pharma Report No. 3164, Bayer AG

    Google Scholar 

  • Seuter F (1980) BAY g 5421 — blood-pharmacological investigations. Pharma Report No. 9224, Bayer AG

    Google Scholar 

  • Seuter F, Perzborn E (1980) BAY m 1099 — blood-pharmacological investigations. Pharma Report No. 9523, Bayer AG

    Google Scholar 

  • Seuter F, Perzborn E (1981) BAY o 1248 — blood-pharmacological investigations. Pharma Report No. 10196, Bayer AG

    Google Scholar 

  • Stoepel K (1980) BAY g 5421 — effect on the haemodynamics and on the cardiac contractibility of anesthesized dogs after oral administration. Pharma Report No. 9120, Bayer AG

    Google Scholar 

  • Stoepel K, Keup U (1975) BAY g 5421 — esplanin. Pharmacological screening tests. Pharma Report No. 5721, Bayer AG

    Google Scholar 

  • Thomas H (1981) BAY g 5421 — results of the test for antibacterial, antimycotic and antiparasitic action. Pharma Report No. 10386, Bayer AG

    Google Scholar 

Download references

Authors
  1. W. Puls
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institut für Klinische Pharmakologie, Bayer AG, Aprather Weg, 42096, Wuppertal, Germany

    Jochen Kuhlmann

  2. Krummacher Straße 200, 42115, Wuppertal, Germany

    Walter Puls

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Puls, W. (1996). General Pharmacology of Glucosidase Inhibitors. In: Kuhlmann, J., Puls, W. (eds) Oral Antidiabetics. Handbook of Experimental Pharmacology, vol 119. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-09127-2_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-09127-2_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-62456-1

  • Online ISBN: 978-3-662-09127-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation